John E. Bailey - President and CEO, Director at G1 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
GTHX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John E. Bailey - trading volume in the past year for G1 Therapeutics, Inc.

Holdings reported by John E. Bailey for G1 Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 557,336 $2.38 M $4.27 Jul 1, 2024 Direct
Stock Options (Right to Buy) 201,300 Jan 3, 2024 Direct Common Stock

Transactions reported by John E. Bailey for G1 Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership